A detailed history of Smartleaf Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 14,308 shares of BMY stock, worth $826,430. This represents 0.09% of its overall portfolio holdings.

Number of Shares
14,308
Previous 15,441 7.34%
Holding current value
$826,430
Previous $641 Million 13.65%
% of portfolio
0.09%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $44,934 - $58,632
-1,133 Reduced 7.34%
14,308 $728 Million
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $229,022 - $301,513
5,690 Added 58.35%
15,441 $641 Million
Q1 2024

Oct 07, 2024

SELL
$47.98 - $54.4 $272,862 - $309,372
-5,687 Reduced 36.83%
9,754 $519 Million
Q1 2024

May 02, 2024

BUY
$47.98 - $54.4 $129,066 - $146,336
2,690 Added 38.1%
9,751 $347 Million
Q4 2023

Feb 12, 2024

BUY
$48.48 - $57.85 $342,317 - $408,478
7,061 New
7,061 $359 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.